Navigation Links
DMAA to Develop Disease Management Standards by December

WASHINGTON - The Disease Management Association of America (DMAA) has announced the launch of a programme that aims to uniformly measure and evaluate "outcomes in disease and care management programs."

"This certainly stands among // the disease management community's most significant research efforts to date,” Don Fetterolf, MD, chair of the DMAA Quality and Research Committee said. "Reaching consensus on a relevant and scientifically valid standard for evaluating clinical and financial outcomes is vital to the continued strong growth of disease and care management." Dr. Fetterolf will be in charge of the standards development project, which intends to present concrete results by December at the DMAA's 2006 Disease Management Leadership Forum in Denver in the first week of that month. "Our members clearly understand the potential of this project to greatly expand acceptance of disease management by all payers, public and private," said Dr. Fetterolf, Corporate Vice President, Strategic Initiatives, for Matria Healthcare Inc. Initially the group will collect data on how other organization collate their d\own data on disease outcomes. "The DMAA recognized that a gap exists in our understanding of best practices for evaluating disease and care management programs," DMAA Executive Director Tracey Moorhead said. "Our experience shows disease management works, but lack of agreement on how to measure that success has hampered our ability to convince skeptics."

The Disease Management Association of America is a non-profit, voluntary membership association representing all stakeholders in the disease management industry through public and private advocacy targeting the health care industry, government agencies, employers and the general public in an effort to educate them on the important role disease management and care coordination programs play in improving healthcare quality and outcomes for persons with chronic conditions.

Fore more in formation visit

Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Risk Of Developing Arthritis
4. Developing HIV fighter
5. Missing Protein In Cancer Development
6. Tomatoes Might Inhibit the Development Of Prostate Cancer
7. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
8. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
9. Men Who at Risk Of Developing Prostate Cancer
10. Identifying The Risks Of Developing Schizophrenia
11. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
Post Your Comments:

(Date:11/27/2015)... ... 27, 2015 , ... An inventor, from Hopkinsville, Ky., thought ... at home, so he invented the patent-pending ELECTRONIC M.D. , The ELECTRONIC M.D. ... doing so, it could help to prevent potential overdose situations. As a result, ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping in mind challenges ... health and wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular ... experienced by parents and bring advice from parenting experts within their reach. As ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer and ... of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. ... 5.10 up-to-date with a version of Asterisk that will receive not only security ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... workshops to discuss bioavailability and the need to integrate dose form selection in ... collaboration with OBN, the membership organization supporting and bringing together the UK’s emerging ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie voor ... ) --> ... ) Uit ... Centrum (LUMC) blijkt ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Japanese therapeutic drug monitoring market, including emerging tests, ...
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda SyMRI ... (MR-bilder) för patienter med multipel skleros ... forskningsavtal med SyntheticMR AB för att kunna ... på sjukhuset. Med SyMRI kan man generera ...
Breaking Medicine Technology: